Summary
This prediction ended on 02.09.22 with a price of €0.95. The BUY prediction by LeMirak for 2curex Ab performed very badly with a performance of -39.16%. LeMirak has 100% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| 2curex Ab | - | - | - |
| iShares Core DAX® | 1.851% | 5.158% | 17.711% |
| iShares Nasdaq 100 | 1.573% | 2.589% | 39.053% |
| iShares Nikkei 225® | -0.412% | -2.857% | 13.501% |
| iShares S&P 500 | 1.128% | 2.485% | 29.871% |
According to LeMirak what are the pros and cons of 2curex Ab for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
High Investments for future growth
ROE higher than 15% per year
Small challenges to pay loans and raise capital
Very capable Management
Strong uniques
Small Risks for its business
Very positive Cash Flow expected
Undervalued
Very good company culture
Leading role in innovation
Very differentiated customer and product portfolio
Market Leader or Top 3
Very small cyclical dependencies
Well known brand
Very Future proof/growth oriented business model
Cons
Comments by LeMirak for this prediction
In the thread 2curex Ab diskutieren
Buy mit Kursziel 55,0